491 related articles for article (PubMed ID: 6202102)
1. Some biological features of Proteus bacilli. 2. Haemolytic activities of Proteus mirabilis and Proteus vulgaris strains.
Kotelko K; Kaca W; Rózalski A; Deka M
Acta Microbiol Pol; 1983; 32(4):345-51. PubMed ID: 6202102
[TBL] [Abstract][Full Text] [Related]
2. Some biological features of proteus bacilli. 3. Comparison of haemolytic activity of Proteus and Serratia strains.
Rózalski A; Wykrota M
Acta Microbiol Pol; 1986; 35(1-2):57-9. PubMed ID: 2426926
[TBL] [Abstract][Full Text] [Related]
3. Some biological features of Proteus bacilli. 1. Comparison of Proteus mirabilis strains provided from various sources.
Kotelko K; Rozalski A; Deka M; Kaca W; Sidorczyk Z; Gromska W; Zych K
Acta Microbiol Pol; 1983; 32(4):339-44. PubMed ID: 6202101
[TBL] [Abstract][Full Text] [Related]
4. Production and properties of haemolysins from clinical isolates of the Proteeae.
Senior BW; Hughes C
J Med Microbiol; 1988 Jan; 25(1):17-25. PubMed ID: 3275780
[TBL] [Abstract][Full Text] [Related]
5. Characterization of cell-bound and cell-free hemolytic activity of Proteus strains.
Kaca W; Rózalski A
Eur J Epidemiol; 1991 Mar; 7(2):159-65. PubMed ID: 2044713
[TBL] [Abstract][Full Text] [Related]
6. [Investigation of hydrophobicity of Proteus vulgaris strains and ability of Proteus vulgaris and Proteus penneri strains to penetrate bladder membrane HCV T-29 cells ].
Bartodziejska B; Błaszczyk A; Wykrota M; Kwil I; Babicka D; Rózalski A
Med Dosw Mikrobiol; 2002; 54(4):335-45. PubMed ID: 12650056
[TBL] [Abstract][Full Text] [Related]
7. [Characteristics of Proteus mirabilis hemolysins].
Parkhomenko LV; Lukach IG; Dykhovichnaia DE
Mikrobiol Zh (1978); 1986; 48(6):24-9. PubMed ID: 3078173
[No Abstract] [Full Text] [Related]
8. Haemolytic activity of Morganella morganii strains.
Gołuszko P; Gospodarek E; Bugalski R
Acta Microbiol Pol; 1988; 37(1):65-71. PubMed ID: 2462333
[TBL] [Abstract][Full Text] [Related]
9. Characterization and serological classification of O-specific polysaccharide of Proteus mirabilisTG 276-90 from Proteus serogroup O34.
Kołodziejska K; Siwińska M; Zych K; Rózalski A; Sidorczyk Z
Arch Immunol Ther Exp (Warsz); 2006; 54(3):223-6. PubMed ID: 16736109
[TBL] [Abstract][Full Text] [Related]
10. The secreted hemolysins of Proteus mirabilis, Proteus vulgaris, and Morganella morganii are genetically related to each other and to the alpha-hemolysin of Escherichia coli.
Koronakis V; Cross M; Senior B; Koronakis E; Hughes C
J Bacteriol; 1987 Apr; 169(4):1509-15. PubMed ID: 3549692
[TBL] [Abstract][Full Text] [Related]
11. Immunochemical studies on the O-antigens of Proteus mirabilis O23 and Proteus vulgaris O23.
Rózalski A; Perepelov AV; Bartodziejska B; Senchenkova SN; Babicka D; Kaca W; Knirel YA
Arch Immunol Ther Exp (Warsz); 2003; 51(1):69-74. PubMed ID: 12691306
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of Proteus mirabilis and Proteus vulgaris strains by means of proticine typing: a longitudinal epidemiological study.
Sekaninová G; Kolárová M
Cent Eur J Public Health; 1996 May; 4(2):98-101. PubMed ID: 8996720
[TBL] [Abstract][Full Text] [Related]
13. Structure of the O-polysaccharide of Proteus mirabilis O19 and reclassification of certain Proteus strains that were formerly classified in serogroup O19.
Perepelov AV; Rózalski A; Bartodziejska B; Senchenkova SN; Knirel YA
Arch Immunol Ther Exp (Warsz); 2004; 52(3):188-96. PubMed ID: 15247885
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the haemolytic activity of Proteus mirabilis strains.
Peerbooms PG; Verweij AM; MacLaren DM
Antonie Van Leeuwenhoek; 1983 Apr; 49(1):1-11. PubMed ID: 6351736
[TBL] [Abstract][Full Text] [Related]
15. [Response to antibiotics of Proteus strains isolated from different types of clinical material].
Ovetchin PV; Tsyganenko AIa
Antibiotiki; 1984 Apr; 29(4):272-5. PubMed ID: 6378080
[TBL] [Abstract][Full Text] [Related]
16. Hemolytic activity and invasiveness in strains of Proteus penneri.
Rozalski A; Kotełko K
J Clin Microbiol; 1987 Jun; 25(6):1094-6. PubMed ID: 3597752
[TBL] [Abstract][Full Text] [Related]
17. Uropathogenic properties of Proteus mirabilis and Proteus vulgaris.
Peerbooms PG; Verweij AM; MacLaren DM
J Med Microbiol; 1985 Feb; 19(1):55-60. PubMed ID: 3881591
[TBL] [Abstract][Full Text] [Related]
18. Cell invasiveness of Proteus mirabilis and Proteus vulgaris strains.
Rózalski A; Długońska H; Kotełko K
Arch Immunol Ther Exp (Warsz); 1986; 34(5-6):505-12. PubMed ID: 3296994
[TBL] [Abstract][Full Text] [Related]
19. [Hemagglutinating properties of Proteus mirabilis strains isolated from clinical specimens].
Samet A; Aleksandrowicz I
Med Dosw Mikrobiol; 1989; 41(2):121-9. PubMed ID: 2685483
[TBL] [Abstract][Full Text] [Related]
20. Structure of the glycerol phosphate-containing O-polysaccharides and serological studies of the lipopolysaccharides of Proteus mirabilis CCUG 10704 (OE) and Proteus vulgaris TG 103 classified into a new Proteus serogroup, O54.
Kołodziejska K; Perepelov AV; Zabłotni A; Drzewiecka D; Senchenkova SN; Zych K; Shashkov AS; Knirel YA; Sidorczyk Z
FEMS Immunol Med Microbiol; 2006 Jul; 47(2):267-74. PubMed ID: 16831214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
